Jake M. Stout

Jake M. Stout

Auto-generated profile, based on publicly available information

Jake M. Stout

Department of Biological Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2011 in Genome Biology
Verified
Journal Article
Open access
PDF file
HBHarm van Bakel
Harm van Bakel
JSJake M Stout
Jake M Stout
ACAtina G Cote
Atina G Cote
CTCarling M Tallon
Carling M Tallon
ASAndrew G Sharpe
Andrew G Sharpe
JPJonathan E Page
Jonathan E Page
Background: Cannabis sativa has been cultivated throughout human history as a source of fiber, oil and food, and for its medicinal and intoxicating properties. Selective breeding has produced cannabis plants for specific uses, including high-potency marijuana strains and hemp cultivars for fiber and seed production. The molecular biology underlying cannabinoid biosynthesis and other traits of interest is largely unexplored. Results: We sequenced genomic DNA and RNA from the marijuana strain Purple Kush using shortread approaches. We report a draft haploid genome sequence of 534 Mb and a transcriptome of 30,000 genes. Comparison of the transcriptome of Purple Kush with that of the hemp cultivar 'Finola' revealed that many genes encoding proteins involved in cannabinoid and precursor pathways are more highly expressed in Purple Kush than in 'Finola'. The exclusive occurrence of Δ9-tetrahydrocannabinolic acid synthase in the Purple Kush transcriptome, and its replacement by cannabidiolic acid synthase in 'Finola', may explain why the psychoactive cannabinoid Δ9-tetrahydrocannabinol (THC) is produced in marijuana but not in hemp. Resequencing the hemp cultivars 'Finola' and 'USO-31' showed little difference in gene copy numbers of cannabinoid pathway enzymes. However, single nucleotide variant analysis uncovered a relatively high level of variation among four cannabis types, and supported a separation of marijuana and hemp. Conclusions: The availability of the Cannabis sativa genome enables the study of a multifunctional plant that occupies a unique role in human culture. Its availability will aid the development of therapeutic marijuana strains with tailored cannabinoid profiles and provide a basis for the breeding of hemp with improved agronomic characteristics.

26 August 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JSJason Sawler
Jason Sawler
JSJake M. Stout
Jake M. Stout
KGKyle M. Gardner
Kyle M. Gardner
DHDarryl Hudson
Darryl Hudson
JVJohn Vidmar
John Vidmar
SMSean Myles
Sean Myles
Despite its cultivation as a source of food, fibre and medicine, and its global status as the most used illicit drug, the genus Cannabis has an inconclusive taxonomic organization and evolutionary history. Drug types of Cannabis (marijuana), which contain high amounts of the psychoactive cannabinoid Δ9-tetrahydrocannabinol (THC), are used for medical purposes and as a recreational drug. Hemp types are grown for the production of seed and fibre, and contain low amounts of THC. Two species or gene pools (C. sativa and C. indica) are widely used in describing the pedigree or appearance of cultivated Cannabis plants. Using 14,031 single-nucleotide polymorphisms (SNPs) genotyped in 81 marijuana and 43 hemp samples, we show that marijuana and hemp are significantly differentiated at a genome-wide level, demonstrating that the distinction between these populations is not limited to genes underlying THC production. We find a moderate correlation between the genetic structure of marijuana strains and their reported C. sativa and C. indica ancestry and show that marijuana strain names often do not reflect a meaningful genetic identity. We also provide evidence that hemp is genetically more similar to C. indica type marijuana than to C. sativa strains.

25 November 2009 in The Plant Journal
Verified
Journal Article
Closed access
PDF file
ASAnthony L Schilmiller
Anthony L Schilmiller
JSJake Stout
Jake Stout
JWJing‐Ke Weng
Jing‐Ke Weng
JHJohn Humphreys
John Humphreys
MRMax O. Ruegger
Max O. Ruegger
CCClint Chapple
Clint Chapple

16 July 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SGSteve J. Gagne
Steve J. Gagne
JSJake M. Stout
Jake M. Stout
ELEnwu Liu
Enwu Liu
ZBZakia Boubakir
Zakia Boubakir
SCShawn M. Clark
Shawn M. Clark
JPJonathan E. Page
Jonathan E. Page
Δ 9 -Tetrahydrocannabinol (THC) and other cannabinoids are responsible for the psychoactive and medicinal properties of Cannabis sativa L. (marijuana). The first intermediate in the cannabinoid biosynthetic pathway is proposed to be olivetolic acid (OA), an alkylresorcinolic acid that forms the polyketide nucleus of the cannabinoids. OA has been postulated to be synthesized by a type III polyketide synthase (PKS) enzyme, but so far type III PKSs from cannabis have been shown to produce catalytic byproducts instead of OA. We analyzed the transcriptome of glandular trichomes from female cannabis flowers, which are the primary site of cannabinoid biosynthesis, and searched for polyketide cyclase-like enzymes that could assist in OA cyclization. Here, we show that a type III PKS (tetraketide synthase) from cannabis trichomes requires the presence of a polyketide cyclase enzyme, olivetolic acid cyclase (OAC), which catalyzes a C2–C7 intramolecular aldol condensation with carboxylate retention to form OA. OAC is a dimeric α+β barrel (DABB) protein that is structurally similar to polyketide cyclases from Streptomyces species. OAC transcript is present at high levels in glandular trichomes, an expression profile that parallels other cannabinoid pathway enzymes. Our identification of OAC both clarifies the cannabinoid pathway and demonstrates unexpected evolutionary parallels between polyketide biosynthesis in plants and bacteria. In addition, the widespread occurrence of DABB proteins in plants suggests that polyketide cyclases may play an overlooked role in generating plant chemical diversity.

8 November 2018 in Genome Research
Verified
Journal Article
Open access
PDF file
KLKaitlin U. Laverty
Kaitlin U. Laverty
JSJake M. Stout
Jake M. Stout
MSMitchell J. Sullivan
Mitchell J. Sullivan
HSHardik Shah
Hardik Shah
NGNavdeep Gill
Navdeep Gill
HBHarm van Bakel
Harm van Bakel
Cannabis sativa is widely cultivated for medicinal, food, industrial, and recreational use, but much remains unknown regarding its genetics, including the molecular determinants of cannabinoid content. Here, we describe a combined physical and genetic map derived from a cross between the drug-type strain Purple Kush and the hemp variety “Finola.” The map reveals that cannabinoid biosynthesis genes are generally unlinked but that aromatic prenyltransferase (AP), which produces the substrate for THCA and CBDA synthases (THCAS and CBDAS), is tightly linked to a known marker for total cannabinoid content. We further identify the gene encoding CBCA synthase (CBCAS) and characterize its catalytic activity, providing insight into how cannabinoid diversity arises in cannabis. THCAS and CBDAS (which determine the drug vs. hemp chemotype) are contained within large (>250 kb) retrotransposon-rich regions that are highly nonhomologous between drug- and hemp-type alleles and are furthermore embedded within ∼40 Mb of minimally recombining repetitive DNA. The chromosome structures are similar to those in grains such as wheat, with recombination focused in gene-rich, repeat-depleted regions near chromosome ends. The physical and genetic map should facilitate further dissection of genetic and molecular mechanisms in this commercially and medically important plant.

21 February 2012 in The Plant Journal
Verified
Journal Article
Open access
PDF file
JSJake M. Stout
Jake M. Stout
ZBZakia Boubakir
Zakia Boubakir
SAStephen J. Ambrose
Stephen J. Ambrose
Randy PurvesRandy Purves
Randy Purves
JPJonathan E. Page
Jonathan E. Page
Summary: The psychoactive and analgesic cannabinoids (e.g. Δ9‐tetrahydrocannabinol (THC)) in Cannabis sativa are formed from the short‐chain fatty acyl‐coenzyme A (CoA) precursor hexanoyl‐CoA. Cannabinoids are synthesized in glandular trichomes present mainly on female flowers. We quantified hexanoyl‐CoA using LC‐MS/MS and found levels of 15.5 pmol g−1 fresh weight in female hemp flowers with lower amounts in leaves, stems and roots. This pattern parallels the accumulation of the end‐product cannabinoid, cannabidiolic acid (CBDA). To search for the acyl‐activating enzyme (AAE) that synthesizes hexanoyl‐CoA from hexanoate, we analyzed the transcriptome of isolated glandular trichomes. We identified 11 unigenes that encoded putative AAEs including CsAAE1, which shows high transcript abundance in glandular trichomes. In vitro assays showed that recombinant CsAAE1 activates hexanoate and other short‐ and medium‐chained fatty acids. This activity and the trichome‐specific expression of CsAAE1 suggest that it is the hexanoyl‐CoA synthetase that supplies the cannabinoid pathway. CsAAE3 encodes a peroxisomal enzyme that activates a variety of fatty acid substrates including hexanoate. Although phylogenetic analysis showed that CsAAE1 groups with peroxisomal AAEs, it lacked a peroxisome targeting sequence 1 (PTS1) and localized to the cytoplasm. We suggest that CsAAE1 may have been recruited to the cannabinoid pathway through the loss of its PTS1, thereby redirecting it to the cytoplasm. To probe the origin of hexanoate, we analyzed the trichome expressed sequence tag (EST) dataset for enzymes of fatty acid metabolism. The high abundance of transcripts that encode desaturases and a lipoxygenase suggests that hexanoate may be formed through a pathway that involves the oxygenation and breakdown of unsaturated fatty acids.